Lung
Find timely and clinically-relevant educational resources focused in the area of lung cancer. This includes video archives from conferences and other live programs, webinars, slide decks, and podcasts.
Videos
THE BEST OF LUNG CANCER CONFERENCE 2022
THE BEST OF LUNG CONFERENCE 2022Learning Objectives:...
ESMO 2022 Roundtable Discussion: Lung
ESMO 2022 Roundtable Discussion: LungLearning Objectives:...
Canadian Immuno-Oncology Conference 2022: Lung Cancer – Dr. Natasha Leighl
Learning Objectives: Lorem ipsum dolor sit amet,...
CHICAGO 2022 LUNG ROUNDTABLE DISCUSSION
Learning Objectives: Lorem ipsum dolor sit amet,...
Best of ASCO® Vancouver 2022: Bristol Myers Squibb Symposium: Expert Insights on the Evolving Canadian Treatment Landscape in Advanced NSCLC Without Actionable Driver Mutations – Dr. Barbara Melosky & Dr. Cheryl Ho
Learning Objectives: Lorem ipsum dolor sit amet,...
Best of ASCO® Vancouver 2022: Lung Cancer – Dr. Aliyah Pabani
Learning Objectives: Lorem ipsum dolor sit amet,...
Best of ASCO® Montreal 2022: Lung Cancer – Dr. Elie Kassouf
Best of ASCO® Montreal 2022: Lung CancerLearning...
Best of ASCO® Toronto 2022: Lung Cancer – Dr. Kirstin Perdrizet
Best of ASCO® Toronto 2022: Lung CancerLearning...
Best of ASCO® Toronto 2022: Bristol Myers Squibb Symposium: Expert Insights on the Evolving Canadian Treatment Landscape in Advanced NSCLC – Dr. Rosalyn Juergens & Dr. Adrian Sacher
Best of ASCO® Toronto 2022: Bristol Myers Squibb...
CHICAGO 2022 HIGHLIGHT – LUNG
Presenting Author: Dr. Biagio RicciutiAbstract #:...
Advanced NSCLC – Immunotherapies for Today and Tomorrow
Lorem ipsum dolor sit amet, consectetur adipiscing elit,...
Best of Lung Cancer Summit 2021
Key Content Areas Include: Lorem ipsum dolor sit amet,...
ESMO 2021 Roundtable: LUNG
Key Content Areas Include: Lorem ipsum dolor sit amet,...
Frontline Targeted Therapy for METex14 Skip Mutation in NSCLC: Latest Updates from 2021
Learning Objectives Review METex14 skip mutation-driven...
Podcasts
ESMO 2022 Roundtable Discussion: Lung
ESMO 2022 Roundtable Discussion: LungLearning Objectives:...
THE BEST OF LUNG CONFERENCE 2022
THE BEST OF LUNG CONFERENCE 2022Learning Objectives:...
Canadian Immuno-Oncology Conference 2022: Lung Cancer – Dr. Natasha Leighl
Learning Objectives: Lorem ipsum dolor sit amet,...
CHICAGO 2022 LUNG ROUNDTABLE DISCUSSION
Learning Objectives: Lorem ipsum dolor sit amet,...
Best of ASCO® Vancouver 2022: Bristol Myers Squibb Symposium: Expert Insights on the Evolving Canadian Treatment Landscape in Advanced NSCLC Without Actionable Driver Mutations – Dr. Barbara Melosky & Dr. Cheryl Ho
Learning Objectives: Best of ASCO® Vancouver 2022: Bristol...
Best of ASCO® Vancouver 2022: Lung Cancer – Dr. Aliyah Pabani
Learning Objectives: Best of ASCO® Vancouver 2022: Lung...
Best of ASCO® Montreal 2022: Lung Cancer – Dr. Elie Kassouf
Learning Objectives: Best of ASCO® Montreal 2022: Lung...
Best of ASCO® Toronto 2022: Lung Cancer – Dr. Kirstin Perdrizet
Best of ASCO® Toronto 2022: Lung CancerLearning...
ESMO 2021 Roundtable: Lung Cancer
Key Content Areas Include: This program has been made...
ESMO 2021 ROUNDTABLE: LUNG HER2-mutated (HER2m) Metastatic NSCLC / NSCLC Harboring HER2 Exon 20 Mutations
Key Content Areas Include: This program has been made...
ESMO 2021 ROUNDTABLE: LBA9 – IMpower010: Sites of Relapse and Subsequent Therapy from a Phase III Study of Atezolizumab vs Best Supportive Care After Adjuvant Chemotherapy in Stage IB-IIIA NSCLC
Key Content Areas Include: This program has been made...
ESMO 2021 ROUNDTABLE: EGFR-mutant NSCLC-Beverley LBA 44
Key Content Areas Include: This program has been made...
ESMO 2021 ROUNDTABLE: EGFR-mutant NSCLC-Chrysallis 1 and 2
Key Content Areas Include: This program has been made...
ESMO 2021 ROUNDTABLE: LBA43 Unresectable Stage III NSCLC
Key Content Areas Include: This program has been made...
ESMO 2021 ROUNDTABLE: First Line (1L) Treatement of Advanced NSCLC
Key Content Areas Include: This program has been made...
Best of Lung Cancer Summit 2021
Key Content Areas Include: Lorem ipsum dolor sit amet,...